Brief: Panbela Announces Validation Of European Patent In UK, Italy, Germany, France, And Spain For Claims Of A Novel Process For The Production Of SBP-101
31/10/2023 12:16
Oct 31 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA ANNOUNCES VALIDATION OF EUROPEAN PATENT IN UK,
ITALY,
GERMANY, FRANCE, AND SPAIN FOR CLAIMS OF A NOVEL PROCESS FOR THE
PRODUCTION OF SBP-101
* PANBELA THERAPEUTICS INC - PATENT IS VALID UNTIL 2039.
Source text for Eikon: ID:nGNXb4lcLh
Further company coverage: PBLA.O
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants